HIPAA & Health Information Notice
Effective September 30, 2026
PlexusDx, Inc. is a technology and administrative platform. PlexusDx is not the medical practice providing your clinical care.
Independent medical provider
Clinical services accessed through PlexusDx are provided independently by Lone Star Virtual Health and its licensed healthcare professionals. Lone Star controls medical evaluation, diagnosis, treatment recommendations, prescribing, dose changes, and decisions to continue or discontinue treatment.
HIPAA and clinical records
Lone Star and participating dispensing pharmacies may be covered entities under the Health Insurance Portability and Accountability Act and maintain their own privacy obligations and notices. Lone Star's Notice of Privacy Practices governs health information maintained as part of its clinical relationship with you.
PlexusDx may create, receive, maintain, or transmit protected health information on behalf of a covered entity when acting as a business associate under an applicable agreement or as otherwise permitted by law. PlexusDx uses such information for authorized functions such as platform operations, care coordination, patient support, pharmacy and fulfillment coordination, billing administration, quality assurance, security, and technical operations.
Medical records requests
Requests for records maintained by Lone Star as part of the medical record should be handled through the applicable Lone Star or Bask Health medical-record process. PlexusDx support can help route a request but does not independently alter the medical record.
PlexusDx information outside HIPAA
Some information PlexusDx handles may not be protected by HIPAA. Such information remains subject to the PlexusDx Privacy Policy and, where applicable, state consumer health data and general privacy laws.
Contact
Questions about PlexusDx's handling of health information may be sent to support@plexusdx.com. Questions or requests specifically concerning Lone Star's clinical records or Notice of Privacy Practices should be directed through the applicable Lone Star or Bask Health process.
PlexusDx, Inc.
6110 McFarland Station Drive, #604
Alpharetta, GA 30004
support@plexusdx.com
Patient portal: https://my.plexusdx.com.
Important information
Compounded medications are not approved by the FDA or reviewed for quality, safety, or efficacy.
Novo Nordisk, Inc. is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus®, Ozempic®, and Wegovy®.
Lilly USA LLC is the only United States company with FDA-approved products containing tirzepatide, identified under the trade names Zepbound® and Mounjaro®.
The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.
